Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization

scientific article published in January 2008

Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1440-1827.2008.02282.X
P698PubMed publication ID18067636

P50authorKyoung-Mee KimQ88377030
P2093author name stringYoon-La Choi
Jae J Han
Eun Y Cho
Young L Oh
P2860cites workExpression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasisQ35011020
P433issue1
P921main subjectimmunohistochemistryQ899285
P304page(s)17-25
P577publication date2008-01-01
P1433published inPathology InternationalQ15758750
P1476titleExpression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization
P478volume58

Reverse relations

cites work (P2860)
Q36369621A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas
Q34184464A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma.
Q37399532Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells
Q47135806Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome
Q49879088Correlation of Hormone Receptor and Human Epidermal Growth Factor Receptor-2/neu Expression in Breast Cancer with Various Clinicopathologic Factors
Q35670742E-N-cadherin heterodimers define novel adherens junctions connecting endoderm-derived cells
Q36824370EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast
Q39167876Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer
Q39563462Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer
Q33692284Expression of cell cycle proteins in male breast carcinoma
Q54353413Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients.
Q33606675Germline mutations and polymorphisms in the origins of cancers in women
Q104471840Iron elevates mesenchymal and metastatic biomarkers in HepG2 cells
Q54670763Kinases and cancer
Q46799794MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas
Q35784682Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor
Q26853543Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival
Q54699349Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
Q36147178Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification
Q34004801Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis
Q47399931Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
Q39503251Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma
Q91825040Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma
Q31121792Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors
Q55069791The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer.
Q34146018miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice

Search more.